LAUSR

Overcoming Endocrine Resistance in Breast Cancer.

Sign Up to like & get
recommendations!
1 Published in 2020 at "Cancer cell"

DOI: 10.1016/j.ccell.2020.03.009

Abstract: Estrogen receptor-positive (ER+) breast cancer is the most common breast cancer subtype. Treatment of ER+ breast cancer comprises interventions that suppress estrogen production and/or target the ER directly (overall labeled as endocrine therapy). While endocrine… read more here.

Keywords: cancer; overcoming endocrine; endocrine resistance; breast cancer ... See more keywords